Nilobutin study

[racerCP]

How do I apply for the Georgetown nilobutin phase II study?

[park_bear]

Do you mean nilotinib?

[racerCP in reply to park_bear]

Yes. Bad spelling but do you have any information

[jeffreyn]

If you click on the link I included in my recent post, you will get to the "trial record" at the Clinical Trials website, where you can check your eligibility.

Towards the end of the trial record is a section titled "Contacts and Locations" where you will find names, email addresses and phone numbers.

Here is a link to my recent post:

healthunlocked.com/parkinso...

[rhenry45]

The Georgetown study was flawed. longecity.org/forum/index.p... It looks like the people doing the original study overlooked the fact that people in the study were taking MAO inhibitors and when they stopped, they each got an increase in natural dopamine. So, basically it was not the Nilotnib that increased the dopamine but rather the cessation of the Azilect they were taking. It looks to me that Nilotnib does not work and is at the minimum very risky to take as it can extend the long QT interval in your heart and cause sudden death in some people. Not a risk I for one am willing to take. Also, Nilotnib accumulates in you over time and can cause this sudden death problem. You have to get an EKG before you start the Nilotnib and then after taking it so you can make sure it is not extending your long QT interval too much, otherwise you are playing with fire.

[jeffreyn in reply to rhenry45]

The article linked to can also be found here:

content.iospress.com/articl...